Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Total Funding:
$10M
Headquarters:
Taipei, T'ai-pei, Taiwan
Funding Status:
Early Stage Venture
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Technology:
diagnostics
Last Funding Date:
2020-02-26
Investors Number:
4
Founded Date:
2015-01-01
Industry:
Biotechnology, Health Care, Life Science